Literature DB >> 18160522

Fluoroquinolone-resistant mutants of Burkholderia cepacia.

C F Pope1, S H Gillespie, J R Pratten, T D McHugh.   

Abstract

Fluoroquinolone-resistant Burkholderia cepacia mutants were selected on ciprofloxacin. The rate of mutation in gyrA was estimated to be 9.6 x 10(-11) mutations per division. Mutations in gyrA conferred 12- to 64-fold increases in MIC, and an additional parC mutation conferred a large increase in MIC (>256-fold). Growth rate, biofilm formation, and survival in water and during drying were not impaired in strains containing single gyrA mutations. Double mutants were impaired only in growth rate (0.85, relative to the susceptible parent).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160522      PMCID: PMC2258500          DOI: 10.1128/AAC.00799-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations.

Authors:  J Zhou; Y Dong; X Zhao; S Lee; A Amin; S Ramaswamy; J Domagala; J M Musser; K Drlica
Journal:  J Infect Dis       Date:  2000-07-24       Impact factor: 5.226

2.  Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.

Authors:  S Bagel; V Hüllen; B Wiedemann; P Heisig
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

3.  A METHOD FOR THE DETERMINATION OF THE RATE OF GROWTH OF TUBERCLE BACILLI BY THE USE OF SMALL INOCULA.

Authors:  G P Youmans; A S Youmans
Journal:  J Bacteriol       Date:  1949-08       Impact factor: 3.490

4.  Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates.

Authors:  Stephen H Gillespie; Shreya Basu; Anne L Dickens; Denise M O'Sullivan; Timothy D McHugh
Journal:  J Antimicrob Chemother       Date:  2005-06-14       Impact factor: 5.790

5.  Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.

Authors:  O J Billington; T D McHugh; S H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

6.  Survival of nosocomial pathogenic bacteria at ambient temperature.

Authors:  S M Smith; R H Eng; F T Padberg
Journal:  J Med       Date:  1996

7.  The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae.

Authors:  J M Sierra; J G Cabeza; M Ruiz Chaler; T Montero; J Hernandez; J Mensa; M Llagostera; J Vila
Journal:  Clin Microbiol Infect       Date:  2005-09       Impact factor: 8.067

Review 8.  Fluoroquinolones: action and resistance.

Authors:  Karl Drlica; Muhammad Malik
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

9.  Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae.

Authors:  Stephen H Gillespie; Leroy L Voelker; Anne Dickens
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

10.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

View more
  11 in total

Review 1.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

2.  Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations.

Authors:  Anjali N Kunz; Afrin A Begum; Hong Wu; Jonathan A D'Ambrozio; James M Robinson; William M Shafer; Margaret C Bash; Ann E Jerse
Journal:  J Infect Dis       Date:  2012-04-05       Impact factor: 5.226

3.  Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics.

Authors:  Lucas A Meirelles; Elena K Perry; Megan Bergkessel; Dianne K Newman
Journal:  PLoS Biol       Date:  2021-03-10       Impact factor: 8.029

4.  In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.

Authors:  John J LiPuma; Sivaprakash Rathinavelu; Bridget K Foster; Jordan C Keoleian; Paul E Makidon; Linda M Kalikin; James R Baker
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

5.  Key role for efflux in the preservative susceptibility and adaptive resistance of Burkholderia cepacia complex bacteria.

Authors:  Laura Rushton; Andrea Sass; Adam Baldwin; Christopher G Dowson; Denise Donoghue; Eshwar Mahenthiralingam
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

Review 6.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

7.  The contribution of antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates: an emphasis on efflux pump activity.

Authors:  Sung-Pin Tseng; Wan-Chi Tsai; Chih-Yuan Liang; Yin-Shiou Lin; Jun-Wei Huang; Chung-Yu Chang; Yu-Chang Tyan; Po-Liang Lu
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

Review 8.  Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria.

Authors:  Miklos Fuzi; Dora Szabo; Rita Csercsik
Journal:  Front Microbiol       Date:  2017-11-16       Impact factor: 5.640

Review 9.  Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.

Authors:  Viola C Scoffone; Laurent R Chiarelli; Gabriele Trespidi; Massimo Mentasti; Giovanna Riccardi; Silvia Buroni
Journal:  Front Microbiol       Date:  2017-08-22       Impact factor: 5.640

10.  Highly Diversified Pandoraea pulmonicola Population during Chronic Colonization in Cystic Fibrosis.

Authors:  Chloé Dupont; Fabien Aujoulat; Raphaël Chiron; Pauline Condom; Estelle Jumas-Bilak; Hélène Marchandin
Journal:  Front Microbiol       Date:  2017-10-06       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.